MaxCyte, Inc.
MXCT
$1.04
-$0.05-4.59%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 32.29M | 33.03M | 34.42M | 35.75M | 37.68M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.29M | 33.03M | 34.42M | 35.75M | 37.68M |
| Cost of Revenue | 6.29M | 6.22M | 6.89M | 7.23M | 7.19M |
| Gross Profit | 25.99M | 26.80M | 27.53M | 28.53M | 30.48M |
| SG&A Expenses | 41.46M | 46.29M | 51.57M | 55.56M | 55.95M |
| Depreciation & Amortization | 4.18M | 4.23M | 4.21M | 4.18M | 4.14M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 70.71M | 77.56M | 84.77M | 89.07M | 88.73M |
| Operating Income | -38.42M | -44.53M | -50.35M | -53.31M | -51.05M |
| Income Before Tax | -39.12M | -44.63M | -45.63M | -44.77M | -41.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -39.12 | -44.63 | -45.63 | -44.77 | -41.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.12M | -44.63M | -45.63M | -44.77M | -41.79M |
| EBIT | -38.42M | -44.53M | -50.35M | -53.31M | -51.05M |
| EBITDA | -34.17M | -40.23M | -46.05M | -49.01M | -46.75M |
| EPS Basic | -0.37 | -0.42 | -0.43 | -0.42 | -0.40 |
| Normalized Basic EPS | -0.19 | -0.22 | -0.25 | -0.26 | -0.25 |
| EPS Diluted | -0.37 | -0.42 | -0.43 | -0.42 | -0.40 |
| Normalized Diluted EPS | -0.19 | -0.22 | -0.25 | -0.26 | -0.25 |
| Average Basic Shares Outstanding | 426.63M | 425.70M | 424.51M | 423.01M | 421.25M |
| Average Diluted Shares Outstanding | 426.63M | 425.70M | 424.51M | 423.01M | 421.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |